Peptide Synthesizer is an instrument used for peptide synthesis according to the principle of solid phase peptide synthesis. Peptides are used to prepare epitope-specific antibodies, map antibody epitopes and enzyme binding sites and to design novel enzymes, drugs and vaccines. Peptide synthesis is characterized as the formation of a peptide bond between two amino acids.
China is the emerging market of peptide synthesizer. Thanks to supportive policies, the development of peptide synthesizer market in China will be faster and faster. Now, peptide synthesizers imported has occupied a large market share in China, and there is still a considerable gap between synthesizer made in China and abroad.
For the application, today, most peptide synthesizers are applied in labs, both in universities and pharm companies. The market of peptide synthesizers used for commercial production is still limited, which is expected to get a large development once the peptide therapy industry makes a breakthrough.


According to this study, over the next five years the Peptide Synthesizer market will register a 2.7% CAGR in terms of revenue, the global market size will reach US$ 76 million by 2024, from US$ 65 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Peptide Synthesizer business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Peptide Synthesizer market by product type, application, key manufacturers and key regions and countries.

This study considers the Peptide Synthesizer value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3: and forecast to 2024 in section 11.7.
Mcg~mg
Mg~g
G~kg
>kg
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4: and forecast to 2024 in section 11.8.
School laboratory
Biopharmaceutical Company
Synthesis Services Company

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
AAPPTec
PTI
PSI
CEM
Biotage
Shimadzu
Activotec
CS Bio
Intavis AG
Hainan JBPharm

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Peptide Synthesizer consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Peptide Synthesizer market by identifying its various subsegments.
Focuses on the key global Peptide Synthesizer manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Peptide Synthesizer with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Peptide Synthesizer submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.